IE 11 is not supported. For an optimal experience visit our site on another browser.

Sanofi withdraws Mulsevo application in EU

PARIS (Reuters) - Sanofi has withdrawn its application to sell Mulsevo, a drug to prevent blood clots in chemotherapy patients, in the European Union after it failed to win the backing of the U.S. regulator last month, the European Medicines Agency said on Monday.
/ Source: Reuters

PARIS (Reuters) - Sanofi has withdrawn its application to sell Mulsevo, a drug to prevent blood clots in chemotherapy patients, in the European Union after it failed to win the backing of the U.S. regulator last month, the European Medicines Agency said on Monday.

Sanofi said in its withdrawal letter that it decided to withdraw all applications globally following comments by regulatory agencies, the EMA said in a statement.

(Reporting by Elena Berton; Editing by James Regan)